Vectra 3D spot-on solution for dogs 4-10kg, 1 pipette
Vectra 3D spot-on solution for dogs 4-10kg, 1 pipette INDICATIONS Fleas: Treatment and prevention of flea infestation (Ctenocephalides felis and Ctenocephalides canis). The treatment prevents flea infestation for one month. It also prevents flea breeding for two months after application by inhibiting the hatching of eggs (ovicidal activity) and by inhibiting the emergence of adults from eggs laid by adult fleas (larvicidal activity). The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis. Ticks: The veterinary medicinal product has acaricidal efficacy and persistent repellent effect against tick infestations (Rhipicephalus sanguineus and Ixodes ricinus for one month and for Dermacentor reticulates for up to three weeks). If ticks are present at the time of application, they may not die within the first 48 hours, but they may die within one week. It is recommended to use an appropriate device to remove ticks. Phlebotomies, (sand flies) mosquitoes and stable flies. The treatment provides a persistent repellent action. It prevents bites by sandflies (Phelbotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and barn flies (Stomoxys calcitrans) for one month after application. The treatment also provides a persistent insecticidal activity for one month against mosquitoes (Aedes aegypti) and barn flies. CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not administer to cats. Due to their unique physiology and inability to metabolise permethrin, this veterinary medicinal product should not be administered to cats. If applied to cats or ingested by a cat, this veterinary medicinal product may have harmful effects. ADVERSE REACTIONS Very rarely, erythema, pruritus or other signs of discomfort at the application site have been reported, which disappear spontaneously within less than 24 hours after administration of the product. Also very rarely, gastrointestinal reactions such as vomiting or diarrhea have been reported. TARGET SPECIES Dogs. DOSAGE FOR EACH SPECIES, ROUTE(S) OF ADMINISTRATION AND METHOD OF ADMINISTRATION Spot-on administration. Care must be taken to ensure that the product is applied to intact skin. Dosage: The minimum recommended dose is 6.4 mg dinotefuran/kg body weight, 0.6 mg pyriproxyfen/kg body weight and 46.6 mg permethrin/kg body weight, which is equivalent to 0.12 ml of veterinary medicinal product/kg body weight. The following table shows which type of spot-on applicator can be used according to the dog's weight. Dog weight (kg) color COVER applicator volume (ml) The applicator used For dogs 1.5-4 kg Yellow 0.8 1 applicator Vectra 3D for dogs 1.5-4kg For dogs 4-10 kg Turquoise 1.6 Vectra 3D for dogs 4-10kg For dogs 10-25 kg Blue 3.6 Vectra 3D for dogs 10-25kg For dogs 25-40 kg Violet 4.7 Vectra 3D for dogs 25-40kg 40 kg Red 8.0 40kg Treatment regimen: After a single administration, the veterinary medicinal product will prevent infestation for one month. The treatment can be repeated once a month if recommended by the veterinarian. WAITING TIME That's not the case. SPECIAL WARNING(S) All dogs in the household should be treated. Cats should be treated with a medicinal product authorised for use in this species. Fleas may infest the dog's bedding, bedding and resting areas such as carpets or interior decorations. In the event of a heavy flea infestation, these areas should be treated with an appropriate insecticide at the start of control measures and then vacuumed regularly. Do not administer to cats. If the product has been accidentally ingested it may cause convulsions in cats, which may be fatal. In the event of accidental exposure, wash the cat with shampoo or soap and seek veterinary advice immediately. To prevent accidental exposure of cats to this veterinary medicinal product, keep cats separate from treated dogs until the application site is dry. It is important that cats do not lick the application site of the veterinary medicinal product on dogs. In the event of such exposure, seek veterinary advice. SPECIAL PRECAUTIONS FOR USE IN ANIMALS For external use only. The safety of the veterinary medicinal product has not been established in puppies under 7 weeks of age or weighing less than 1.5 kg. Care should be taken to avoid contact of the veterinary medicinal product with the dog's eyes. After treatment, tick attachment cannot be excluded, therefore transmission of infectious diseases cannot be completely excluded if conditions are favourable. The product remains effective when dogs are introduced into water (bathing, swimming). Repeated weekly introduction into water for one month and starting within 48 hours of treatment as well as shampooing 2 weeks after treatment do not affect the efficacy of the product. However, in the case of frequent shampooing or bathing less than 48 hours after treatment, the duration of activity of the product may be reduced. Treated dogs should not enter surface waters for 48 hours after treatment to avoid adverse effects on aquatic organisms. GESTA AND LACTATION The safety of the veterinary medicinal product has not been established during pregnancy and lactation in bitches. The use of the product in pregnant or lactating bitches, or in dogs used for breeding, should be based on the benefit/risk ratio by the veterinarian. Laboratory studies with each component, dinotefuran, pyriproxyfen or permethrin in rats and rabbits did not produce any maternotoxic, teratogenic or fetotoxic effects. Dinotefuran has been observed to cross the blood-milk barrier and is excreted in milk. It has been shown that N-methylpyrrolidone, an excipient of the veterinary medicinal product, has a teratogenic effect on laboratory animals. incompatibility Do not mix with any other veterinary medicinal product and do not apply together with another veterinary medicinal product at the same time and in the same place. DOSAGE Apart from erythema and cosmetic changes to the coat at the application site, no other adverse reactions were observed in 7-week-old puppies treated topically 7 times at 2-week intervals with doses up to 5 times the recommended dose. After accidental ingestion of the maximum recommended dose, vomiting, salivation and diarrhoea may occur. However, these signs resolve without the need for treatment. Product compliance information Product compliance information Product safety Manufacturer information Personal information Product safety information Currently, product safety information is not available. Manufacturer information Currently, manufacturer information is not available. Responsible person information Currently, information about the person responsible is not available. \n Presentation type: Pipette Action: Ticks, Fleas, Mosquitoes, Flies Dog Weight: 4-10 kg Pieces Set: 1 piece Brand Name: Vectra \n Quantity: 1 Pipettes